SHC
Sotera Health Co
18.30$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.1% | -2.3% | -0.1% | +3.0% | -2.4% | +0.8% | +3.8% | -1.0% | +2.4% | -0.8% | +2.2% | |
| – | +7.2% | -12.6% | +2.2% | +13.2% | -6.7% | +5.5% | +9.6% | -5.0% | +6.2% | -4.5% | +10.3% | |
| – | +21.0% | -11.9% | -5.8% | +24.6% | -9.6% | +9.8% | +9.2% | -9.4% | +15.1% | -8.8% | +12.9% | |
| – | +21.0% | -11.9% | -5.8% | +24.6% | -9.6% | +9.8% | +9.2% | -9.4% | +15.1% | -8.8% | +12.9% | |
| – | -0.4% | -19.4% | +13.5% | +10.0% | -6.1% | -7.6% | +17.4% | +8.6% | -9.7% | +0.0% | +12.1% | |
| – | +27.4% | +6.3% | +12.7% | -7.3% | -8.4% | +24.2% | -1.8% | -8.3% | +8.0% | +5.8% | -1.4% | |
| – | +0.9% | -0.8% | -0.4% | +0.6% | -2.1% | +0.3% | +1.9% | -0.5% | +0.4% | -0.5% | -0.6% | |
| – | -3.0% | -6.2% | -5.8% | -4.3% | -9.8% | -5.5% | -0.1% | -3.1% | -0.9% | -3.1% | -3.3% | |
| – | +1.0% | -2.1% | +0.2% | +1.7% | -0.4% | +0.6% | +0.8% | -2.6% | +0.8% | -1.6% | +1.1% | |
| – | +15.0% | -34.0% | +11.4% | +15.3% | -2.3% | +18.3% | +9.0% | -1.6% | +3.0% | -16.7% | +11.3% | |
| – | -2.5% | -40.5% | +61.1% | +22.5% | -0.5% | +0.7% | +3.1% | -3.2% | +1.3% | +0.7% | -0.9% | |
| – | +24.4% | -13.3% | +4.7% | +9.7% | -22.1% | +27.2% | -9.2% | -3.6% | +27.0% | -1.6% | +31.7% | |
| – | +0.0% | +0.0% | -0.5% | -0.1% | -0.1% | -0.1% | -0.1% | -3.3% | -0.1% | -0.1% | +0.1% | |
| – | +17.6% | -3.2% | -1.5% | +11.2% | -13.9% | +2.3% | +23.5% | +7.7% | +10.1% | +2.7% | +6.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.8% | +0.3% | +0.2% | +0.4% | -0.2% | -0.5% | +0.8% | +0.3% | -0.1% | +0.4% | +0.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.